09:19 AM EDT, 06/02/2026 (MT Newswires) -- Healthcare stocks were lower premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) down 0.1% and the iShares Biotechnology ETF (IBB) easing 0.3%.

Hims & Hers Health ( HIMS ) stock was up more than 2% after the company said it has completed its acquisition of Eucalyptus, expanding its consumer health platform across Australia, Canada, Germany, and other international markets.

Heron Therapeutics ( HRTX ) shares were down 18% after the company said the US District Court for the District of Delaware has ruled that claims in two of its Cinvanti injectable emulsion patents are invalid.

Telix Pharmaceuticals ( TLX ) and United Imaging Healthcare North America signed a memorandum of understanding for a research collaboration in the US focused on integrated theranostics solutions. Telix Pharmaceuticals ( TLX ) stock was down more than 2% pre-bell.